Minimal residual disease (MRD) detection in acute lymphoblastic leukaemia based on fusion genes and genomic deletions: towards MRD for all

Minimal residual disease (MRD) diagnostics are implemented in most clinical protocols for patients with acute lymphoblastic leukaemia (ALL) and are mostly performed using rearranged immunoglobulin (IG) and/or T‐cell receptor (TR) gene rearrangements as molecular polymerase chain reaction targets. Un...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuiper, Roland P., Hoogeveen, Patricia G., Bladergroen, Reno, van Dijk, Freerk, Sonneveld, Edwin, van Leeuwen, Frank N., Boer, Judith, Sergeeva, Irina, Feitsma, Harma, den Boer, Monique L., van der Velden, Vincent H. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Haematological malignancy ‐ Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291030/
https://www.ncbi.nlm.nih.gov/pubmed/34337744
http://dx.doi.org/10.1111/bjh.17744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291030/
https://www.ncbi.nlm.nih.gov/pubmed/34337744
http://dx.doi.org/10.1111/bjh.17744

Ejemplares similares